Related Experiment Videos
Reduction in infarct size by synchronized selective coronary venous retroperfusion of arterialized blood
Insights
Early coronary venous retroperfusion significantly reduces heart attack size. Combining this with later reperfusion therapy preserved ischemic myocardium, decreasing infarct size by 84% in baboon models.
Area of Science:
- Cardiovascular Research
- Myocardial Infarction
- Ischemic Heart Disease
Background:
- Selective synchronized pulsatile coronary venous retroperfusion (SCVP) offers temporary metabolic support to ischemic myocardium.
- Previous studies demonstrated SCVP's effectiveness in supporting acutely ischemic heart regions.
Purpose of the Study:
- To assess the reduction in ultimate infarct size when SCVP is initiated early after coronary occlusion, followed by later anterograde reperfusion.
- To evaluate the combined effect of early SCVP and subsequent reperfusion on myocardial salvage.
Main Methods:
- 10 baboons underwent a 4-hour occlusion of the left anterior descending coronary artery, followed by reperfusion.
- Group A (n=5) received SCVP 15 minutes post-occlusion; Group B (n=5) did not receive SCVP.
- Epicardial electrograms monitored ischemic regions; infarct size was determined stereometrically via nitroblue tetrazolium staining at 24 hours.
Main Results:
- Group A showed significantly fewer ST-segment elevations evolving to Q waves (12% vs. 96%, p<0.01) compared to Group B.
- Infarct size was dramatically reduced in Group A (4.8% of left ventricular mass) versus Group B (30.6%, p<0.01).
- The combined therapy resulted in an 84% mean reduction in ultimate infarct size.
Conclusions:
- Early initiation of SCVP is highly effective in preserving ischemic myocardium.
- Combining early SCVP with later anterograde reperfusion significantly reduces infarct size, offering a promising therapeutic strategy for acute myocardial infarction.
Abstract:
The effectiveness of selective synchronized pulsatile coronary venous retroperfusion for the temporary metabolic support of a region of acutely ischemic myocardium has previously been demonstrated. This study was designed to determine the degree of reduction in ultimate infarct size that may be achieved when coronary venous retroperfusion initiated early after coronary occlusion is combined with later anterograde reperfusion. In 10 baboons, the proximal left anterior descending coronary artery was occluded for 4 hours at which time anterograde reperfusion was restored. In five baboons (Group A), coronary venous retroperfusion was initiated 15 minutes after occlusion. Five baboons (Group B) underwent an identical procedure without coronary venous retroperfusion. Epicardial electrograms were recorded from 24 sites overlying the ischemic region. At 24 hours, hearts were excised and serial transverse sections of the left ventricle were stained with nitroblue tetrazolium for stereometric determination of infarct size. In Group A 12 +/- 5.4 percent (mean +/- standard error of the mean) of epicardial sites with S-T segment elevation at 15 minutes after occlusion showed subsequent Q waves, compared with 96 +/- 2.3 percent in Group B (p less than 0.01). In Group A 4.8 +/- 1.7 percent of the left ventricular mass was infarcted, compared with 30.6 +/- 4.2 percent in Group B (p less than 0.01). The results demonstrated the effectiveness of coronary venous retroperfusion in preserving ischemic myocardium such that anterograde reperfusion resulted in a mean reduction of 84 percent in ultimate infarct size.